Chemoinformaics analysis of 8-hydroxy-7-methoxy-2H-chromen-2-one
| Molecular Weight | 192.17 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 12 |
| Exact Molecular Weight | 192.042 | nRing | 2 |
| Solubility: LogS | -2.246 | nHRing | 1 |
| Solubility: LogP | 1.032 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 25.2423 |
| nHD | 1 | BPOL | 12.3657 |
| QED | 0.695 |
| Synth | 2.208 |
| Natural Product Likeliness | 1.287 |
| NR-PPAR-gamma | 0.681 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.019 |
| HIA | 0.008 |
| CACO-2 | -4.764 |
| MDCK | 0.0000204 |
| BBB | 0.104 |
| PPB | 0.864614 |
| VDSS | 0.739 |
| FU | 0.160438 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.149 |
| CYP2c19-sub | 0.116 |
| CYP2c9-inh | 0.079 |
| CYP2c9-sub | 0.813 |
| CYP2d6-inh | 0.692 |
| CYP2d6-sub | 0.809 |
| CYP3a4-inh | 0.189 |
| CYP3a4-sub | 0.29 |
| CL | 13.601 |
| T12 | 0.852 |
| hERG | 0.015 |
| Ames | 0.448 |
| ROA | 0.343 |
| SkinSen | 0.339 |
| Carcinogencity | 0.889 |
| EI | 0.535 |
| Respiratory | 0.345 |
| NR-Aromatase | 0.538 |
| Antiviral | No |
| Prediction | 0.762794 |